BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15673962)

  • 1. Transitional cell carcinoma of the bladder in four patients on maintenance hemodialysis.
    Horiuchi K; Uchikoba T; Oka F; Sato M; Kondo Y; Kimura G; Tsuboi N; Yoshida K; Nishimura T
    J Nippon Med Sch; 2004 Dec; 71(6):408-11. PubMed ID: 15673962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of bladder cancer in patients with chronic renal failure].
    Uchida T; Takekawa K; Omata T; Mukai N; Egawa S; Mashimo S; Endo T; Koshiba K
    Hinyokika Kiyo; 1993 Dec; 39(12):1167-70. PubMed ID: 8285166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan.
    Chang CH; Yang CM; Yang AH
    Cancer; 2007 Apr; 109(8):1487-92. PubMed ID: 17330839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transitional cell carcinoma of bladder occurring during pregnancy: report of two patients].
    Kimura F; Sakamoto H; Shimizu S; Nakajima F; Nakamura H
    Nihon Hinyokika Gakkai Zasshi; 1994 Nov; 85(11):1683-6. PubMed ID: 7807778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penile and urethral metastases from superficial bladder tumor after TUR: a case report].
    Takahashi S; Ozono S; Cho M; Fujimoto K; Sasaki K; Hirao Y; Okajima E
    Hinyokika Kiyo; 1989 Jun; 35(6):1055-9. PubMed ID: 2801393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.
    Pieras E; Palou J; Salvador J; Rosales A; Marcuello E; Villavicencio H
    Eur Urol; 2003 Aug; 44(2):222-5; discussoion 225. PubMed ID: 12875942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
    Sato Y; Kondo T; Takagi T; Junpei I; Tanabe K
    Int Urol Nephrol; 2016 Apr; 48(4):503-9. PubMed ID: 26759324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
    Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
    BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three cases of transitional cell carcinoma in bladder diverticulum treated by a bladder-preserving approach].
    Aizawa T; Mamiya Y; Tochimoto M; Ito T; Shiozawa H; Tujino S; Yamamoto S; Miki M; Ishibashi K
    Hinyokika Kiyo; 1999 Feb; 45(2):111-3. PubMed ID: 10212784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urothelial tumor in dialysis patients; report of four cases].
    Tomomasa H; Amemiya H; Iizumi T; Yazaki T; Umeda T; Chimata M; Hidaka S; Takeda K; Kakuta S; Okada H
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1139-44. PubMed ID: 2287107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
    Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
    Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
    J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
    Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
    Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.